Tue, October 11, 2011
[ Tue, Oct 11th 2011 ]: Market Wire
Aetna??Michael Elliott???????
Mon, October 10, 2011
Sun, October 9, 2011
Sat, October 8, 2011
Fri, October 7, 2011
Thu, October 6, 2011
Wed, October 5, 2011
Tue, October 4, 2011
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ]: Market Wire
Medwell Capital to Adopt IFRS
Sun, October 2, 2011
Sat, October 1, 2011
Fri, September 30, 2011
Thu, September 29, 2011
Wed, September 28, 2011
Tue, September 27, 2011
Mon, September 26, 2011
Sat, September 24, 2011
Fri, September 23, 2011
Thu, September 22, 2011
Wed, September 21, 2011
Tue, September 20, 2011
Mon, September 19, 2011
Sun, September 18, 2011
Sat, September 17, 2011
Fri, September 16, 2011
Thu, September 15, 2011
Wed, September 14, 2011
Tue, September 13, 2011

Millennium y Seattle Genetics presentan datos clnicos sobre ADCETRISTM (Brentuximab Vedotin) en pacientes peditricos en reunin


//health-fitness.news-articles.net/content/2011/ .. b-vedotin-en-pacientes-peditricos-en-reunin.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


CAMBRIDGE, Mass. & BOTHELL, Wash.--([ BUSINESS WIRE ])--[ Millennium: The Takeda Oncology Company ], una filial propiedad al 100% de Takeda Pharmaceutical Company Limited (TSE:4502) y Seattle Genetics, Inc. (Nasdaq: SGEN), ha presentado los datos de un anlisis retrospectivo de los pacientes peditricos (de 12 a 17 aos) inscritos en cuatro ensayos clnicos multicentro (dos de fase I y dos de fase II) de ADCETRIS. Todos los pacientes fueron diagnosticados con linfoma de Hodgkin recurrente o refractario (HL) (n=5) o linfoma anaplstico sist©mico de c©lulas grandes (sALCL) (n=4) y no han tenido ©xito con al menos un r©gimen de quimioterapia anterior. Los datos se han presentado en una sesin en el Congreso Europeo Multidisciplinario sobre el Cncer, que se celebra del 23 al 27 de septiembre en Estocolmo (Suecia).


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear